Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ionis Pharmaceuticals

31.86
-1.7850-5.31%
Pre-market: 31.30-0.5600-1.76%04:17 EDT
Volume:1.96M
Turnover:63.48M
Market Cap:5.07B
PE:-10.63
High:33.67
Open:33.00
Low:31.80
Close:33.65
Loading ...

Catalyst (CPRX) Soars 16.7%: Is Further Upside Left in the Stock?

Zacks
·
09 Jan

Denali Therapeutics' Amyotrophic Lateral Sclerosis Misses Pivotal Trial, But Analyst Says It Was Expected

Benzinga
·
08 Jan

Analysts Offer Insights on Healthcare Companies: Ionis Pharmaceuticals (IONS) and Anteris Technologies Global Corp. (AVR)

TIPRANKS
·
07 Jan

Ionis Pharmaceuticals Inc : Bofa Global Research Cuts Price Objective to $65 From $66

THOMSON REUTERS
·
06 Jan

AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?

Zacks
·
06 Jan

Denali Therapeutics Neurodegenerative Disease Platform Sparks Analyst Optimistic

Benzinga
·
04 Jan

Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)

TIPRANKS
·
25 Dec 2024

Investors Don't See Light At End Of Ionis Pharmaceuticals, Inc.'s (NASDAQ:IONS) Tunnel

Simply Wall St.
·
23 Dec 2024

Analysts Conflicted on These Healthcare Names: Ionis Pharmaceuticals (IONS) and UnitedHealth (UNH)

TIPRANKS
·
23 Dec 2024

U.S. RESEARCH ROUNDUP-Hershey, Paychex, Revvity

Reuters
·
23 Dec 2024

Intellia Crashes 60% in a Year: How Should You Play the Stock?

Zacks
·
21 Dec 2024

Ionis FDA approval a positive for Arrowhead, says H.C. Wainwright

TIPRANKS
·
20 Dec 2024

Ionis Gets FDA Approval for Rare Disease Drug Tryngolza

Zacks
·
20 Dec 2024

FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood

Benzinga
·
20 Dec 2024

BUZZ-Ionis Pharma rises as FDA approves genetic disorder drug

Reuters
·
20 Dec 2024

Ionis Pharmaceuticals reports FDA approval of Tryngolza

TIPRANKS
·
20 Dec 2024

Ionis Pharmaceuticals Says FDA Approved Familial Chylomicronemia Syndrome Drug

MT Newswires Live
·
20 Dec 2024

Ionis Pharmaceuticals trading resumes

TIPRANKS
·
20 Dec 2024

BRIEF-Tryngolza (Olezarsen) Approved In U.S. As First-Ever Treatment For Adults Living With Familial Chylomicronemia Syndrome As An Adjunct To Diet

Reuters
·
20 Dec 2024

Tryngolza™ (Olezarsen) Approved in U.S. as First-Ever Treatment for Adults Living With Familial Chylomicronemia Syndrome as an Adjunct to Diet

THOMSON REUTERS
·
20 Dec 2024